Cingulate (CINGW) Other Non-Current Assets (2022 - 2025)
Cingulate's (CINGW) quarterly Other Non-Current Assets came in at $59383.0 in Q4 2025, up 331.47% quarter-over-quarter from $13763.0 in Q3 2024.
Analysis
Cingulate (CINGW) Other Non-Current Assets (2022 - 2025) Analysis & Trends
Cingulate (CINGW) has reported Other Non-Current Assets for 4 consecutive years, with $59383.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets changed N/A year-over-year to $59383.0; the trailing twelve-month figure through Dec 2025 stood at $59383.0 (changed N/A YoY), and the FY2025 full-year result was $59383.0, changed N/A from the prior year.
- Other Non-Current Assets rose to $59383.0 in Q4 2025 per CINGW's latest filing, from $13763.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $178780.0 in Q4 2023 and bottomed at $13763.0 in Q3 2024.
- Historically, Other Non-Current Assets has averaged $84342.8 across 4 years, with a median of $69449.0 in 2024.
- The widest YoY moves for Other Non-Current Assets: up 78.18% in 2023, down 78.18% in 2023.
- Over 4 years, Other Non-Current Assets stood at $100339.0 in 2022, then soared by 78.18% to $178780.0 in 2023, then tumbled by 92.3% to $13763.0 in 2024, then jumped by 331.47% to $59383.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $59383.0, $13763.0, and $69449.0 for Q4 2025, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 9.94 Bn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 5.50 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | 42.45 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 86.76 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 239.50 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 59,383.00 |
| Sep 30, 2024 | 13,763.00 |
| Jun 30, 2024 | 69,449.00 |
| Dec 31, 2023 | 178,780.00 |
| Dec 31, 2022 | 100,339.00 |